The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
4don MSN
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...
Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results